Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021
July 22 2021 - 4:05PM
Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a
specialty pharmaceutical company developing medicines for
addictions and drug overdose, today announced it will report
its financial results for the second quarter ended June 30, 2021,
after the financial markets close on Thursday, August 5, 2021.
The Company’s management team is scheduled to host a conference
call and webcast at 4:30 p.m. ET on Thursday, August
5, 2021. To access the call, please dial 888-394-8218 in
the U.S. or 323-794-2588 outside the U.S. and
provide the conference ID number: 5960603. To access the live
webcast, please visit http://public.viavid.com/index.php?id=145669.
Following the live webcast, an archived version of the call will be
available on the website.
Thursday August 5 @ 4:30 pm
ET
Domestic: |
888-394-8218 |
International: |
323-794-2588 |
Conference ID: |
5960603 |
Webcast: |
http://public.viavid.com/index.php?id=145669 |
About Opiant Pharmaceuticals,
Inc.Opiant Pharmaceuticals, Inc., the company that
developed NARCAN® Nasal Spray, is building a leading franchise of
new medicines to combat addictions and drug overdose. For more
information visit: www.opiant.com.
For Media and Investor Inquiries:Ben Atkins,
Opiant(310) 598-5410batkins@opiant.com
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Sep 2023 to Sep 2024